CSR Program: Bridges to Development | Takeda Pharmaceuticals
Innovation and elimination of neglected tropical diseases: maximizing impact for challenging island communities
Providing care and treatment against neglected tropical diseases, empowering communities, training health workers and strengthening health systems
The Program
Partner: Bridges to Development
Budget: 681 million yen
Term: 3 years
Launch: 2020
Area: Papua New Guinea and Vanuatu
Visit the Bridges to Development website
Over 1.5 billion people worldwide are affected by neglected tropical diseases (NTD) even though early prevention and treatment are available. Many hard-to-reach communities of the Pacific islands remain at high risk for NTD infections and carry a disproportionate burden of these diseases. This partnership helps decrease the burden and removes the need for any large-scale interventions against NTDs in the future by eliminating and controlling targeted NTDs (lymphatic filariasis, yaws, leprosy, trachoma, scabies and soil-transmitted helminthiases).
Have more questions?
Contact us if you'd like more information about our Global CSR Program.